Published May 15, 2026
| Version v1
Preprint
Open
Wild-type Abl1 kinase targeting in TNBC with nilotinib.
Authors/Creators
Description
We present here evidence for a general oncogene targeting approach using a small molecule inhibitor of Abl1 kinase in TNBC for oncogene addiction.